D
Protagonist Therapeutics, Inc. PTGX
$58.36 $2.173.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -13.57% -105.62% 381.70% 2.62% 20.40%
Total Depreciation and Amortization -2.24% -1.46% -35.58% -21.77% 8.65%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 23.56% 48.87% 20.56% 27.23% -1.37%
Change in Net Operating Assets -101.33% 151.24% -918.96% -389.32% 7,144.00%
Cash from Operations -110.71% 557.05% -272.04% -4.70% 1,123.79%
Capital Expenditure -2,803.57% -125.21% -1,531.58% -91.83% 84.09%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 163.14% -1,586.73% 86.27% -1,480.65% -439.62%
Cash from Investing 162.20% -1,654.97% 85.76% -1,439.27% -442.05%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 13.72% 52.87% 664.90% -65.88% -97.64%
Repurchase of Common Stock -- 20.17% -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 13.72% 58.95% 664.90% -65.88% -97.62%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -84.18% 399.48% 22.67% -4,524.55% 69.99%